Additionally, bone marrow samples from pediatric B-ALL patients who were CNS-positive presented significantly higher levels of CD79A protein than those from patients who were CNS-negative [30]. The gene discussed is CD79A; the disease is precursor B-cell acute lymphoblastic leukemia.